JW Pharmaceutical Corporation (KRX:001065)
South Korea · Delayed Price · Currency is KRW 27,750
+150 (0.54%)
At close: Nov 24, 2025
JW Pharmaceutical Market Cap
JW Pharmaceutical has a market cap or net worth of 600.19 billion as of November 26, 2025. Its market cap has decreased by -2.58% in one year.
Market Cap
600.19B
Enterprise Value
586.35B
Revenue
764.21B
Ranking
n/a
PE Ratio
10.25
Stock Price
27,750.00
Market Cap Chart
Since April 29, 2003, JW Pharmaceutical's market cap has increased from 84.02B to 600.19B, an increase of 614.33%. That is a compound annual growth rate of 9.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 600.19B | 6.85% |
| Dec 30, 2024 | 561.70B | -32.21% |
| Dec 28, 2023 | 828.52B | 97.41% |
| Dec 29, 2022 | 419.69B | -17.00% |
| Dec 30, 2021 | 505.68B | -32.85% |
| Dec 30, 2020 | 753.06B | 22.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.32T |
| Celltrion | 39.84T |
| ALTEOGEN | 27.70T |
| SK Biopharmaceuticals | 10.10T |
| ABL Bio | 9.54T |
| Yuhan | 8.55T |
| Peptron | 7.43T |
| LigaChem Biosciences | 6.25T |